EPIRUS Biopharmaceuticals, Inc. announced that Mr. Amit Munshi, the company's President and Chief Executive Officer and a member of its Board of Directors has resigned from each of those positions. On May 6, 2016, the Board appointed Scott Rocklage, Ph.D., a current member of the Board, as the Company's acting Chief Executive Officer. On May 6, 2016, the Board appointed Michael Wyand, DVM, Ph.D., as the Company's President and Chief Operating Officer.